BROOKTREE CAPITAL MANAGEMENT - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 124 filers reported holding CARDLYTICS INC in Q4 2022. The put-call ratio across all filers is 1.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
BROOKTREE CAPITAL MANAGEMENT ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$1,967,493
+158.4%
119,242
-1.0%
1.64%
+183.8%
Q2 2023$761,295
+91.9%
120,458
+3.1%
0.58%
+87.4%
Q1 2023$396,753
+66.3%
116,864
+183.2%
0.31%
+57.7%
Q4 2022$238,529
-73.7%
41,268
-57.2%
0.20%
-73.8%
Q3 2022$907,000
+19.5%
96,520
+183.6%
0.75%
+31.1%
Q2 2022$759,000
-26.0%
34,034
+82.6%
0.57%
-14.7%
Q1 2022$1,025,00018,6410.67%
Other shareholders
CARDLYTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders